Theromics Inc

Theromics has developed a novel, safe Thermal Accelerant used during the microwave, RFA, or cryoablation procedures of soft tissue, fibroids, and bone HeatSYNC can augment the reach of thermal energy from a distance normally unattainable by microwave or radiofrequency devices, thus high-power energy is not needed. The gel is also being studied for use as a drug delivery system combined with thermal ablation for a new therapy called TACT - Thermally Activated Combination Therapy. Caution: This device is for Investigational Use Only and has not been cleared by the FDA or other regulatory bodies.

Cancer,interventional oncology,microwave ablation,radiofrequency ablation,cancer surgery,interventional radiology,ob-gyn,cancer therapy,fda,medical device,oncology,thermal ablation,clinical trials,and brown university

Theromics inc operates in the Biotechnology industry.

Theromics inc's revenue is 11m - 100m

Theromics inc has 11 - 50 employees.